Silence Therapeutics Plc (SLNCF)
Silence Therapeutics Market Cap : 334.42M for April 30, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Adaptimmune Therapeutics Plc | 2.650M |
| Biodexa Pharmaceuticals Plc | 2.036M |
| Oxford Biomedica Plc | 1.028B |
| NuCana Plc | 8.865M |
| Autolus Therapeutics Plc | 375.26M |
Market Cap Related Metrics
| PS Ratio | 598.21 |
| PEG Ratio | -0.3053 |
| Price to Book Value | 5.368 |
| Price | 2.36 |
| Earnings Yield | -26.50% |
| PEGY Ratio | -0.3053 |